Apotex Backs Teva's En Banc Bid In Skinny Label Fight
By Tiffany Hu · October 21, 2021, 6:51 PM EDT
Generic-drug maker Apotex is asking the full Federal Circuit to let it weigh in on Teva's request for the appeals court to once again reconsider its decision to hold Teva liable...
To view the full article, register now.